Pars compacta

From WikiMD's WELLNESSPEDIA

Pars compacta is a portion of the substantia nigra, a basal ganglia structure located in the midbrain that plays a crucial role in reward, addiction, and movement. The pars compacta is one of the two parts of the substantia nigra, the other being the pars reticulata.

Structure[edit]

The pars compacta is characterized by its dense population of dopaminergic neurons. These neurons are responsible for producing dopamine, a neurotransmitter that plays a key role in the regulation of movement, mood, and reward. The neurons in the pars compacta send projections to the striatum, another part of the basal ganglia, where they release dopamine.

Function[edit]

The primary function of the pars compacta is the production and release of dopamine. This neurotransmitter is crucial for the normal functioning of the basal ganglia and the execution of smooth, coordinated movements. In addition to its role in movement, dopamine from the pars compacta also contributes to the reward system of the brain, influencing motivation, pleasure, and reinforcement learning.

Clinical significance[edit]

Damage or degeneration of the neurons in the pars compacta is associated with several neurological disorders. The most notable of these is Parkinson's disease, a neurodegenerative disorder characterized by the loss of dopaminergic neurons in the pars compacta. This loss leads to a decrease in striatal dopamine levels, resulting in the characteristic motor symptoms of Parkinson's disease, such as tremors, rigidity, and bradykinesia.

Other conditions associated with the pars compacta include Schizophrenia, where there is thought to be an overactivity of the dopaminergic neurons, and drug addiction, where drugs of abuse can alter the function of these neurons and the release of dopamine.

See also[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.